arrow
L

Luca Scafuri

irccs fondazione pascale
H指数:11
被引数:580

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PEACE: Development and Validation of a Brief Five-Item Sleep Quality Scale for Community and Primary Care

PEACE:适用于社区和初级保健的简短五项睡眠质量量表的研制与验证

2026-04-150
OA
BLOSSOM Dietary Habits and 1-Year Intravesical Recurrence in High-Risk Non-Muscle-Invasive Bladder Cancer Treated with BCG

BLOSSOM饮食习惯与接受BCG治疗的高风险非肌层浸润性膀胱癌患者1年内腔内复发

2026-02-270
OAAI
Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

PREVES-HOR问卷的开发与验证:一种用于接受雄激素剥夺治疗的前列腺癌患者激素疗法相关生活质量的自评量表

2025-09-010
PRE
Study on the Impact of Hormone Therapy for Prostate Cancer on the Quality of Life and the Psycho-Relational Sphere of Patients: ProQoL

前列腺癌激素治疗对患者生活质量和心理-关系领域影响的研究:ProQoL

2024-11-131
OAAI
The Impact of Flavonoid Supplementation on Serum Oxidative Stress Levels Measured via D-ROMs Test in the General Population: The PREVES-FLAVON Retrospective Observational Study
2024-09-291
OAAI
Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy

基于曲妥珠单抗Deruxtecan联合内分泌治疗探索HER2-Low ER阳性乳腺癌经典化疗的新方法

2024-06-280
OAAI
Gender minorities in breast cancer - Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients

乳腺癌中的性别少数群体-临床试验入组差异: 关注男性,跨性别和性别多样化的患者

BREAST
IF7.9
2024-06-011
OAAI
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond
2024-02-281
OAAI
A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario
2023-12-191
OAAI
Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone

比较癌症患者的心血管不良事件: 血管生成抑制剂和免疫检查点抑制剂联合治疗与单独使用血管生成抑制剂的荟萃分析

2023-08-0118
PRE
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy

基于顺铂的新辅助化疗方案下膀胱癌患者的风险组分类模型

2021-07-194
PRE
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis

局部肌层浸润性膀胱癌行根治性膀胱切除术3周期与4周期新辅助化疗: 多机构回顾性分析

2021-05-1114
OAAI
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings
2021-01-0138
PREAI
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis
2020-07-0137
PRE